Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    CP1.AX Current Ratio

    As of 2025-05-20, the Current Ratio of CANNPAL ANIMAL THERAPEUTICS ORD (CP1.AX) is 5.82.

    Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

    CP1.AX Current Ratio - Historical Value
    DateValue
    2020-06-30 5.82
    2019-06-30 23.22
    2018-06-30 39.54
    2017-06-30 19.5
    -
    -
    -
    -
    -
    -
    CP1.AX Current Ratio - Peers Comparison
    TickerNameValue
    204840.KQGL Pharm Tech Corp1.37
    4586.TMedrx Co Ltd19.63
    AC8.AXAuscann Group Holdings Ltd49.47
    ACR.AXAcrux Ltd4.14
    AGH.AXAlthea Group Holdings Ltd0.64
    ANP.AXAntisense Therapeutics Ltd4.51
    AVE.AXAvecho Biotechnology Ltd2.81
    BOT.AXBotanix Pharmaceuticals Ltd22.21
    CAN.AXCann Group Ltd0.21
    CGB.AXCann Global Ltd2.95
    ECS.AXECS Botanics Holdings Ltd5.07
    IDT.AXIDT Australia Ltd1.34
    IVX.AXInvion Ltd18.7
    IXC.AXInvex Therapeutics Ltd14.18
    LGP.AXLittle Green Pharma Ltd3.34
    MXC.AXMGC Pharmaceuticals Ltd0.19
    NEU.AXNeuren Pharmaceuticals Ltd8.73
    NYR.AXNyrada Inc25.35
    PAA.AXNeurizon Therapeutics Ltd12.42
    PXS.AXPharmaxis Ltd2.33
    RCE.AXRecce Pharmaceuticals Ltd0.34
    RNO.AXRhinomed Ltd0.27
    SPL.AXStarpharma Holdings Ltd4.94
    VLS.AXVita Life Sciences Ltd3.06
    WFL.AXWellfully Ltd0.58
    ZLD.AXZelira Therapeutics Ltd0.6
    Tickers added to watchlist